Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience.

Saved in:
Bibliographic Details
Title: Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience.
Authors: Jang H; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kim JW; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Department of Neurology, Soon Chun Hyang University Hospital Bucheon, Bucheon, South Korea., Hwang JW; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Jeong DW; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Ka J; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kang DM; Degree Course in Medicine and Surgery, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Suh CH; Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Choi Y; Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Oh M; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kim JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lim JS; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. jaesunglim@amc.seoul.kr., Lee JH; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1758-9193
DOI:10.1186/s13195-026-02141-1